Fenwick & West represented Nurx Inc., a health tech company providing convenient and affordable care for sensitive health needs, in raising an additional $52 million in funding. The Series C round was led by Kleiner Perkins Digital Growth Fund and Union Square Ventures with participation from Reproductive Health Investors Alliance, Dreamers VC, Lowercase Capital and Y Combinator, as well as Triple Point Capital for equity and debt.

Nurx will use the funds to introduce more services for sensitive health needs, as well as grow its patient community to reach more people who face systemic barriers to healthcare. The company will also focus on expanding its medical provider team and investing in its telemedicine platform to continue improving and streamlining the patient experience. More information about Nurx’s $52 million in additional funding can be obtained from the company announcement.

The Fenwick transaction team was led by corporate partners Michael Esquivel and Faisal Rashid and associates Will Black, Elliot Ginsburg and Harrison Dilday.

Login

Don’t have an account yet?

Register